Evaluate the Safety and Efficacy of Botulax® Versus Botox® in Patient With Overactive Bladder

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 12, 2020

Primary Completion Date

April 26, 2021

Study Completion Date

October 26, 2021

Conditions

Overactive Bladder

Interventions

DRUG

Botulinum toxin type A injection

Experimental

DRUG

Botulinum Toxin Type A Injection [Botox]

Active Comparator

Trial Locations (1)

Hugel, Seoul

All Listed Sponsors

lead

Hugel

INDUSTRY

NCT04186442 - Evaluate the Safety and Efficacy of Botulax® Versus Botox® in Patient With Overactive Bladder | Biotech Hunter | Biotech Hunter